AcquisitionOther
First Light Acquisition Group, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
First Light Acquisition Group, Inc. -> target · $42 million
Calidis pipeline includes two off-the-shelf clinical programs, NeuroNova (CLD-101) and SuperNova (CLD-201), which utilize allogeneic stem cell technologies loaded with either vaccinia virus or adenovirus, being developed in partnership with leading research
Open source record (SEC) ↗